| 发布于: | Android | 转发：1 | 回复：6 | 喜欢：0 |
曹彬这个解释非常好。目前情况就是如此。然而就这个结果对全球抗疫已经有非常大的正面影响。
对于中美研究结论的差异，曹彬表示，主要是因为评价终点的不一样。
“同样的高考分，你能上二本，上不了清华北大，标准不同。你说瑞德西韦有效吗，行，他能上大学，那也算是个好孩子，但是他上不...
咦，我就奇了，你确定和我说的是一码事儿？给你copy个18h前NIH发布的瑞德西韦临床试验结果：“Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo (p<0.001). Specifically, the median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo. Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group (p=0.059).” ———注意 第二十个单词 placebo
有对照组啊，p值都很不错。临床试验是设计严格的流程，您的担心多虑了